Can IgM antibodies indicate recent immune activation even when PCR is negative?

IgM is often an early feature of pathogen-specific humoral responses, but an IgM-positive/PCR-negative result is not, on its own, evidence of active infection—particularly in an older adult, where interpretation should be anchored to symptoms, illness duration, and the specific test platform.

Clinical interpretation

• Mycoplasma pneumoniae IgM generally appears about 1 week after symptom onset and peaks at 2–3 weeks, so it can be compatible with a recent immune response. In relapsing-fever Borrelia hermsii, antibody reactivity develops during illness and broadens over 3–4 weeks.
• IgM alone cannot establish ongoing immune activation, viable pathogen replication, or the cause of current symptoms. For M. pneumoniae, IgM may persist for months and occasionally beyond 1 year.
• With suspected Lyme disease, CDC guidance advises generally disregarding isolated IgM positivity after >30 days of illness, because persistent and nonspecific/cross-reactive IgM substantially increase false-positive risk. In prolonged compatible illness, an appropriate IgG response is expected; IgG seronegativity over months to years argues strongly against Lyme disease except with testing error or major humoral immunodeficiency.

PCR discordance and mechanisms

• PCR detects pathogen nucleic acid, whereas serology detects the host immune response; these signals can diverge because antibodies outlast detectable organism burden or because assays recognize cross-reactive antibodies.
• A negative blood PCR does not exclude Lyme disease: blood PCR has limited sensitivity and is not preferred over validated two-tier serology for routine Lyme diagnosis. In seropositive Lyme arthritis, synovial-fluid PCR may provide relevant supporting evidence.
• For M. pneumoniae, late sampling, low organism burden, specimen selection, technical factors, and assay-specific IgM false positivity can produce IgM-positive/PCR-negative results.

Bottom line

• IgM is a plausible marker of recent immune activation, but PCR-negative/IgM-positive discordance more often requires context-specific confirmation than inference of ongoing infection. Validated two-tier serology, appropriately targeted NAAT, and—when indicated—paired serology showing seroconversion or rising IgG titers provide stronger evidence.